Nodal Micrometastases or Isolated Tumor Cells and the Outcome of Breast CancerTJAN-HEIJNEN, Vivianne C. G.Breast disease. 2010, Vol 31, Num 2, issn 0888-6008, 54 p.Serial Issue

Can Radiotherapy Replace Axillary Dissection for Patients with Positive Sentinel Nodes?RECHT, Abram.Breast disease. 2010, Vol 31, Num 2, pp 91-97, issn 0888-6008, 7 p.Article

Prognostic Impact of Isolated Tumor Cells and Micrometastases in Axillary Lymph Nodes of Breast Cancer PatientsTJAN-HEIJNEN, Vivianne C. G; PEPELS, Manon J; DE BOER, Maaike et al.Breast disease. 2010, Vol 31, Num 2, pp 107-113, issn 0888-6008, 7 p.Article

Prediction of Non-SN involvement in patients with SN isolated tumor cells or micrometastasesPESCE, Catherine; BALCH, Charles; JACOBS, Lisa et al.Breast disease. 2010, Vol 31, Num 2, pp 99-106, issn 0888-6008, 8 p.Article

Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literatureRUITERKAMP, Jetske; VOOGD, Adri C; BOSSCHA, Koop et al.Breast cancer research and treatment. 2010, Vol 120, Num 1, pp 9-16, issn 0167-6806, 8 p.Article

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedureTJAN-HEIJNEN, Vivianne C. G; BULT, Peter; DE WIDT-LEVERT, Louise M et al.Breast cancer research and treatment. 2001, Vol 70, Num 2, pp 81-88, issn 0167-6806Article

Characteristics of triple-negative breast cancerDE RUIJTER, Tim C; VEECK, Jürgen; DE HOON, Joep P. J et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 2, pp 183-192, issn 0171-5216, 10 p.Article

Pathology Issues Related to SN Procedures and Increased Detection of Micrometastases and Isolated Tumor CellsVAN DIEST, Paul J; VAN DEURZEN, Carolien H. M; CSERNI, Gábor et al.Breast disease. 2010, Vol 31, Num 2, pp 65-81, issn 0888-6008, 17 p.Article

Axillary Recurrences Following Positive Sentinel Lymph Node Biopsy with Individual Tumor Cells or Micrometastases and No Axillary DissectionERB, Kathleen M; SHAPIRO-WRIGHT, Hilarv M; JULIAN, Thomas B et al.Breast disease. 2010, Vol 31, Num 2, pp 83-90, issn 0888-6008, 8 p.Article

Modeling the Cost Effectiveness of Secondary Febrile Neutropenia Prophylaxis During Standard-Dose ChemotherapyTIMMER-BONTE, Johanna N. H; ADANG, Eddy M. M; TERMEER, Evelien et al.Journal of clinical oncology. 2008, Vol 26, Num 2, pp 290-296, issn 0732-183X, 7 p.Article

A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal womenCARDOSO, Fatima; BISCHOFF, Joachim; BRAIN, Etienne et al.Cancer treatment reviews. 2013, Vol 39, Num 5, pp 457-465, issn 0305-7372, 9 p.Article

High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancerSPAN, Paul N; TJAN-HEIJNEN, Vivianne C. G; MANDERS, Peggy et al.Breast cancer research and treatment. 2006, Vol 98, Num 2, pp 223-230, issn 0167-6806, 8 p.Article

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancerSPAN, Paul N; TJAN-HEIJNEN, Vivianne C. G; MANDERS, Peggy et al.Oncogene (Basingstoke). 2003, Vol 22, Num 31, pp 4898-4904, issn 0950-9232, 7 p.Article

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinomaMANDERS, Peggy; BEEX, Louk V. A. M; TJAN-HEIJNEN, Vivianne C. G et al.Cancer. 2003, Vol 98, Num 10, pp 2125-2132, issn 0008-543X, 8 p.Article

Diagnostic challenges of respiratory adverse events during everolimus treatmentWILLEMSEN, Annclieke E. C. A. B; DE VOS, Filip Y; JANSEN, Anne et al.Targeted oncology. 2014, Vol 9, Num 3, pp 287-291, issn 1776-2596, 5 p.Article

Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic reviewPEPELS, Manon J; VESTJENS, Johanna H. M. J; DE BOER, Maaike et al.Breast cancer research and treatment. 2011, Vol 125, Num 2, pp 301-313, issn 0167-6806, 13 p.Article

Non-Sentinel Lymph Node Metastases Associated With Isolated Breast Cancer Cells in the Sentinel NodeVAN DEURZEN, Carolien H. M; DE BOER, Maaike; MONNINKHOF, Evelyn M et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 22, pp 1574-1580, issn 0027-8874, 7 p.Article

Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancerKOTZSCH, Matthias; FARTHMANN, Juliane; SPAN, Paul N et al.European journal of cancer (1990). 2005, Vol 41, Num 17, pp 2760-2768, issn 0959-8049, 9 p.Article

Morphometry of Isolated Tumor Cells in Breast Cancer Sentinel Lymph Nodes : Metastases or Displacement?VAN DEURZEN, Carolien H. M; BULT, Peter; DE BOER, Maaike et al.The American journal of surgical pathology. 2009, Vol 33, Num 1, pp 106-110, issn 0147-5185, 5 p.Article

Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic reviewVAN DEURZEN, Carolien H. M; VRIENS, Birgit E. P. J; TJAN-HEIJNEN, Vivianne C. G et al.European journal of cancer (1990). 2009, Vol 45, Num 18, pp 3124-3130, issn 0959-8049, 7 p.Article

ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinomaPORTER, Sarah; SPAN, Paul N; SWEEP, Fred C. G. J et al.International journal of cancer. 2006, Vol 118, Num 5, pp 1241-1247, issn 0020-7136, 7 p.Article

Cost-effectiveness of adding granulocyte colony- stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancerTIMMER-BONTE, Johanna N. H; ADANG, Eddy M. M; SMIT, Hans J. M et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 2991-2997, issn 0732-183X, 7 p.Article

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinomaMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer. 2004, Vol 101, Num 3, pp 486-494, issn 0008-543X, 9 p.Article

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. CommentarySPAN, Paul N; LINDBERG, Raija L. P; MANDERS, Peggy et al.Journal of pathology. 2004, Vol 202, Num 4, pp 391-394, issn 0022-3417, 12 p.Article

Predictive impact of urokinase-type plasminogen activator: Plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancerMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer research (Baltimore). 2004, Vol 64, Num 2, pp 659-664, issn 0008-5472, 6 p.Article